ALDH1L1, ALDH3A1, ALDH3B1, and ALDH5A1 may serve as potential prognostic markers and predictors of chemotherapy response in pancreatic cancer patients. This evidence concerns the gene ALDH1L1 and pancreatic neoplasm.